Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Parkinsonism & Related DisordersReferences
- An essay on the shaking palsy.Whittingham and Rowland, London1817
- Diet, body size and micronutrient status in Parkinson’s disease.Eur J Clin Nutr. 1992; 46: 879-884
- Weight change and body composition in patients with Parkinson’s disease.J Am Diet Assoc. 1995; 95: 979-983
- Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment.Clin Auton Res. 1992; 2: 153-157
- Gastrointestinal dysfunction in Parkinson’s disease.Lancet Neurol. 2003; 2: 107-116
- Weight and body mass index in Parkinson’s disease patients after deep brain stimulation surgery.Parkinsonism Relat Disord. 2005; 11: 247-252
- Compulsive eating and weight gain related to dopamine agonist use.Mov Disord. 2006; 21: 524-529
- Oral health conditions in patients with Parkinson’s disease.J Epidemiol. 2004; 14: 143-150
- Increased periodontal pathology in Parkinson’s disease.J Neurol. 2006; 253: 608-611
- Influence of Parkinson’s disease on oral health.Acta Odontol Scand. 1992; 50: 37-42
- Oral health of patients with Parkinson’s disease: factors related to their better dental status.Tohoku J Exp Med. 2003; 201: 171-179
- Bruxism as a presenting feature of Parkinson’s disease.J Assoc Physicians India. 2002; 50: 457
- An appliance for management of TMJ pain as a complication of Parkinson’s disease.Cranio. 1998; 16: 57-59
- Habitual mandibular dislocation in two patients with Parkinson’s disease.Rinsho Shinkeigaku. 1999; 39 ([Japanese]): 849-851
- Burning mouth in Parkinson’s disease sufferers.Gerodontology. 1998; 15: 73-78
- Sialorrhoea and drooling in patients with Parkinson’s disease: epidemiology and management.Drugs Aging. 2008; 25: 1007-1019
- Impact of drooling in Parkinson’s disease.J Neurol. 2007; 254: 1227-1232
- Sialorrhea in Parkinson’s disease: a review.Mov Disord. 2007; 22: 2306-2313
- Alimentary disorder in parkinsonism.Aust Ann Med. 1965; 14: 13-22
- Gastrointestinal symptoms in Parkinson’s disease.Mov Disord. 1991; 6: 151-156
- Salivary symptoms in Parkinson disease.Arch Neurol. 1973; 29: 274-275
- A study of salivary secretion in Parkinson’s disease.Clin Neuropharmacol. 1999; 22: 213-215
- Salivary production in Parkinson’s disease.Mov Disord. 2005; 20: 204-207
- Quantitative study of salivary secretion in Parkinson’s disease.Mov Disord. 2006; 21: 660-667
- Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease?.Parkinsonism Relat Disord. 2008; 14: 243-245
- Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.Mov Disord. 2002; 17: 1318-1320
- Ipratropium bromide spray as treatment for sialorrhea in Parkinson’s disease.Mov Disord. 2007; 22: 2268-2273
- Botulinum toxin: clinical use.Parkinsonism Relat Disord. 2006; 12: 331-355
- Long-term follow-up of tympanic neurectomy for sialorrhea.Laryngoscope. 1979; 89: 1219-1223
- Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson’s disease.Acta Neurol Scand. 1998; 97: 27-35
- Prepharyngeal dysphagia in Parkinson’s disease.Dysphagia. 1996; 11: 14-22
- Swallowing abnormalities and their response to treatment in Parkinson’s disease.Neurology. 1989; 39: 1309-1314
- Pharyngo-esophageal dysphagia in Parkinson’s disease.Dysphagia. 1997; 12: 11-18
- Swallowing difficulty in Parkinson’s disease.Clin Neurol Neurosurg. 1997; 99: 106-112
- Swallowing disorders in Parkinson’s disease.Parkinsonism Relat Disord. 2003; 9: 349-353
- Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients.Age Aging. 1994; 23: 251-254
- Dysphagia, a reversible cause not to be forgotten.Postgrad Med J. 1995; 71: 94-95
- Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.Arch Neurol. 2001; 58: 259-264
- Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson’s disease.Gastroenterology. 1996; 110: 383-392
- Videofluorographic study of swallowing in Parkinson’s disease.Dysphagia. 1998; 13: 95-100
- Swallowing and speech production in Parkinson’s disease.Ann Neurol. 1986; 19: 283-287
- Radiological assessment of dysphagia in Parkinson’s disease.Br J Radiol. 1991; 64: 890-893
- Cricopharyngeal dysfunction in Parkinson’s disease: role in dysphagia and response to myotomy.Mov Disord. 1996; 11: 53-58
- Gastrointestinal dysfunction in Parkinson’s disease. A report of clinical experience at a single center.J Clin Gastroenterol. 1994; 19: 11-16
- Biomechanics of failed deglutitive upper esophageal sphincter relaxation in neurogenic dysphagia.Am J Physiol Gastrointest Liver Physiol. 2002; 283: G16-G26
- Esophageal manometric abnormalities in Parkinson’s disease.Dysphagia. 1998; 13: 28-31
- Manometric abnormalities of the oesophagus in patients with Parkinson’s disease.Neurogastroenterol Motil. 2001; 13: 361-364
- Esophageal disorders and surgery.in: Biller J. The interface of neurology & internal medicine. Lippincott Williams & Wilkins, Philadelphia2008: 217-221
- Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease.Mov Disord. 1996; 11: 729-732
- Botulinum toxin for cricopharyngeal dysfunction in Parkinson’s disease.N Engl J Med. 2002; 346: 1174-1175
- Gastrointestinal dysfunction in Parkinson’s disease.Semin Neurol. 1996; 16: 245-250
- Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.Neurology. 1981; 31: 1288-1294
- Gastric emptying in Parkinson’s disease: patients with and without response fluctuations.Neurology. 1996; 46: 1051-1054
- Gastric emptying time and gastric motility in patients with Parkinson’s disease.Mov Disord. 2001; 16: 1041-1047
- Predictors of gastric emptying in Parkinson’s disease.Neurogastroenterol Motil. 2006; 18: 369-375
- Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease.J Neurol. 2005; 252: 1055-1059
- Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson’s disease.Isr J Med Sci. 1996; 32: 1224-1227
- Erratic gastric emptying of levodopa may cause “random” fluctuations of Parkinsonian mobility.Neurology. 1988; 38: 419-421
- Current management of motor fluctuations in patients with advanced Parkinson’s disease treated chronically with levodopa.J Neural Transm Suppl. 1999; 56: 173-183
- Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson’s disease with a fluctuating response to levodopa.Eur J Clin Pharmacol. 1991; 41: 453-458
- Irregular gastrointestinal drug absorption in Parkinson’s disease.Expert Opin Drug Metab Toxicol. 2008; 4: 193-203
- Gastroparesis: current diagnostic challenges and management considerations.World J Gastroenterol. 2009; 15: 25-37
- Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.Am J Gastroenterol. 2008; 103: 753-763
- Impaired gastric emptying of a solid test meal in patients with Parkinson’s disease using 13C-sodium octanoate breath test.Neurosci Lett. 2005; 375: 170-173
- Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.Clin Neuropharmacol. 2006; 29: 61-67
- Domperidone and levodopa in Parkinson’s disease.Br J Clin Pharmac. 1984; 18: 959-962
- Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease.Mov Disord. 1997; 12: 952-957
- Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management.Drugs Aging. 1997; 10: 249-258
- Effect of cisapride on response fluctuations in Parkinson’s disease.Mov Disord. 1995; 10: 81-84
- Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson’s disease.Parkinsonism Relat Disord. 2005; 11: 499-502
- Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.Am J Gastroenterol. 1993; 88: 485-490
- Oral erythromycin and symptomatic relief of gastroparesis: a systematic review.Am J Gastroenterol. 2003; 98: 259-263
- Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis.J Clin Gastroenterol. 2004; 38: 237-242
- Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment.Psychosomatics. 2006; 47: 440-442
- Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.Dig Dis Sci. 2009 Jan 30; ([epub ahead of print])
- Botulinum toxin type A for treatment of refractory gastroparesis.Am J Health Syst Pharm. 2007; 64: 2237-2240
- Gastric electrical stimulation for gastroparesis.J Am Coll Surg. 2008; 207: 533-538
- Treatment of gastroparesis: an update.Digestion. 2008; 78: 173-179
- Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey.Parkinsonism Relat Disord. 2002; 8: 277-284
- Excess burden of constipation in Parkinson’s disease: a pilot study.Mov Disord. 2006; 21: 1270-1273
- Anorectal function in multiple system atrophy and Parkinson’s disease.Mov Disord. 2000; 15: 71-76
- Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease.Auton Neurosci. 2001; 92: 76-85
- Defecatory disorders in de novo Parkinsonians – colon transit and electromyogram of the external anal sphincter.Wien Klin Wochenschr. 1998; 110: 535-537
- Constipation in Parkinson’s disease: objective assessment and response to psyllium.Mov Disord. 1997; 12: 946-951
- Frequency of bowel movements and the future risk of Parkinson’s disease.Neurology. 2001; 57: 456-462
- Bowel movement frequency in late life and incidental Lewy bodies.Mov Disord. 2007; 22: 1581-1586
- Characterization of swallowing and defecation in Parkinson’s disease.Am J Gastroenterol. 1994; 89: 15-25
- Constipation in Parkinson’s disease.Klin Wochenschr. 1991; 69: 906-909
- The effect of cisapride on delayed colon transit time in patients with idiopathic Parkinson’s disease.Wien Klin Wochenschr. 1994; 106: 673-676
- Colonic transit time and rectoanal videomanometry in Parkinson’s disease.J Neurol Neurosurg Psychiatry. 2003; 74: 268-272
- Measurement of gastrointestinal transit.Dig Dis Sci. 2005; 50: 989-1004
- Management of faecal incontinence and constipation in adults with central neurological diseases.Cochrane Database Syst Rev. 2006; 2: CD002115
- Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study.Mov Disord. 2007; 22: 1239-1244
- Macrogol 3350/electrolyte improves constipation in Parkinson’s disease and multiple system atrophy.Mov Disord. 2001; 16: 1176-1177
- Megacolon and volvulus in Parkinson’s disease.Radiology. 1965; 85: 73-79
- Sigmoid volvulus in association with parkinsonism. Report of four cases.J Am Geriatr Soc. 1987; 35: 683-684
- Manometric investigation of anorectal function in early and late stage Parkinson’s disease.J Neurol Neurosurg Psychiatry. 2000; 68: 768-770
- Pathogenesis of slow transit and pelvic floor dysfunction: from bench to bedside.Rev Gastroenterol Disord. 2004; 4: S17-S27
- Anorectal and pelvic floor dysfunction.in: Quigley E.M.M. Pfeiffer R.F. Neuro-gastroenterology. Butterworth Heinemann, Philadelphia2004: 255-271
- Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon?.J Neurol Neurosurg Psychiatry. 1988; 51: 1503-1507
- Anal sphincter dysfunction in Parkinson’s disease.Arch Neurol. 1989; 46: 1061-1064
- Anorectal manometry in the assessment of anorectal function in Parkinson’s disease: a comparison with chronic idiopathic constipation.Mov Disord. 1994; 9: 655-663
- Anorectal function in fluctuating (on-off) Parkinson’s disease: evaluation by combined anorectal manometry and electromyography.Mov Disord. 1995; 10: 650-657
- Simultaneous electromyography and manometry of the anal sphincters in Parkinsonian patients: technical considerations.Muscle Nerve. 1996; 19: 110-111
- Dyssynergic defecation and biofeedback therapy.Gastroenterol Clin North Am. 2008; 37: 569-586
- The role of biofeedback therapy in functional proctologic disorders.Scand J Surg. 2004; 93: 184-190
- Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients.Int J Colorectal Dis. 2009; 24: 115-120
- Severe constipation in Parkinson’s disease relieved by botulinum toxin.Mov Disord. 1997; 12: 764-766
- Treatment of outlet obstruction constipation in Parkinson’s disease with botulinum neurotoxin A.Am J Gastroenterol. 2003; 98: 1439-1440
- Outlet type constipation in Parkinson’s disease: results of botulinum toxin treatment.Aliment Pharmacol Ther. 2005; 22: 997-1003
- Defecatory function in Parkinson’s disease: response to apomorphine.Ann Neurol. 1993; 33: 490-493
- Overview of morphological changes in Parkinson’s disease.in: Yahr M.D. Bergmann K.J. Parkinson’s disease. Advances in neurology. vol. 45. Raven Press, New York1987: 1-18
- Neuropathology of immunohistochemically identified brainstem neurons in Parkinson’s disease.Ann Neurol. 1990; 27: 373-385
- Where does Parkinson disease pathology begin in the brain?.J Neuropathol Exp Neurol. 2002; 61: 413-426
- Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease.Gastroenterology. 1884; 87: 848-856
- Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells.Neurology. 1987; 37: 1253-1255
- Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses.Acta Neuropathol. 1988; 76: 217-221
- Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology.Neurosci Lett. 2006; 396: 67-72
- Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation.Lancet. 1995; 346: 861-864
- Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.Acta Neuropathol. 1990; 79: 581-583
Article info
Publication history
Footnotes
☆Disclosures (2009–2010): Honoraria for lectures: Boehringer-Ingelheim, Novartis, Teva. Honoraria for consulting: Solvay, Theravance, Genactis, Schlesinger Associates. Research Grants/Contracts: Novartis, Boehringer-Ingelheim, UCB/Schwarz, Santhera, Molecular Biometrics. Royalties (for books edited): CRC Press (Taylor & Francis), Humana Press. Legal Consulting: Spriggs & Hollingsworth, Davis Graham & Stubbs, Tucker Ellis & West.
☆☆This paper was presented at the XVIII WFN World Congress on Parkinson's Disease and Related Disorders Miami December 2009.
☆☆☆The review of this paper was entirely handled by the Co-Editor-in-Chief Prof. Z.K. Wszolek.